New faculty who joined VP&S in recent months include a specialist in managing infections in immunocompromised patients and a researcher of precision cellular immunotherapies for autoimmunity.
Columbia has one of six new sites launched by the NIH's Breast Cancer and Environment Research Program for prevention and research across the lifespan.